Old Blood Cells Have Been Transformed Into Brain Stem Cells That Get Younger As They Age.
Aging is the price paid for the ability of experiencing existence, one might philosophize.
Natural cellular aging begins with differentiation. Once a stem cell becomes a specific cell type, it’s locked in forever: fat cells can never become muscle cells, no matter how hard one wishes, or pokes and prods at them in front of the mirror.
Or so it goes in nature, but scientists can definitely transform cells, as if biologically compensating for all the failed alchemical attempts of the past.
Now, scientists have transformed old blood cells into young brain stem cells, which continued to grow younger as they grew older.
The researchers, from the University Hospital of Bonn and the University of Bonn, in Germany, described their methods in the journal Aging Cell.
Cellular transformations can be done in two main ways. The first, more circuitous route turns a specific cell back into a pluripotent stem cell, or an embryonic “blank slate,” and then into a different cell type.
The second method involves a “direct conversion,” which skips the middle stage and directly transforms a cell into a different type.
“Using this method, we have directly converted red blood cell precursors into neural stem cells,” summarizes Oliver Brüstle, the director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn.
The researchers used donor cells from 15 people across the age spectrum, from newborn to 101 years of age.
They specifically took erythroid progenitor cells (EPCs), which are akin to red blood cells that haven’t graduated college yet, and turned them into induced neural stem cells (iNSCs), which are the pre-graduate cells of the brain.
They achieved the direct conversion genetic shortcut via an unlikely agent that usually destroys cells.
The researchers used a virus to deliver two transcription factors, or proteins that attach to DNA to regulate gene activity, to get the cells to change their types.
Then they used two genome-bloodhounding methods – DNA methylation measures and RNA sequencing – to track the resultant anti-aging effects and genetic behavior.
By the 12th day after the viral “infection,” the cells started showing their new identity, ditching their blood-like proteins and replacing them with the expression of neural-like proteins instead.